loading . . . La dolce vita: fueling chimeric antigen receptor (CAR) T... : Immunometabolism y of patients relapse, which is concomitant with poor CAR T cell persistence. Similarly, the efficacy of CAR T cell therapy is limited in solid tumors, largely due to tumor antigen heterogeneity, immu... https://journals.lww.com/immunometabolism/fulltext/2025/01000/la_dolce_vita__fueling_chimeric_antigen_receptor.3.aspx#
